<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN" "http://jats.nlm.nih.gov/publishing/1.2/JATS-journalpublishing1.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.2" xml:lang="en">
    <front>
        <journal-meta>
            <journal-id journal-id-type="pmc">F1000Research</journal-id>
            <journal-title-group>
                <journal-title>F1000Research</journal-title>
            </journal-title-group>
            <issn pub-type="epub">2046-1402</issn>
            <publisher>
                <publisher-name>F1000 Research Limited</publisher-name>
                <publisher-loc>London, UK</publisher-loc>
            </publisher>
        </journal-meta>
        <article-meta>
            <article-id pub-id-type="doi">10.12688/f1000research.109992.1</article-id>
            <article-categories>
                <subj-group subj-group-type="heading">
                    <subject>Research Article</subject>
                </subj-group>
                <subj-group>
                    <subject>Articles</subject>
                </subj-group>
            </article-categories>
            <title-group>
                <article-title>The validity and reliability test of the leprosy life quality questionnaire in leprosy patients</article-title>
                <fn-group content-type="pub-status">
                    <fn>
                        <p>[version 1; peer review: 3 approved with reservations]</p>
                    </fn>
                </fn-group>
            </title-group>
            <contrib-group>
                <contrib contrib-type="author" corresp="yes">
                    <name>
                        <surname>Widasmara</surname>
                        <given-names>Dhelya</given-names>
                    </name>
                    <role content-type="http://credit.niso.org/">Conceptualization</role>
                    <role content-type="http://credit.niso.org/">Investigation</role>
                    <role content-type="http://credit.niso.org/">Methodology</role>
                    <role content-type="http://credit.niso.org/">Visualization</role>
                    <role content-type="http://credit.niso.org/">Writing &#x2013; Original Draft Preparation</role>
                    <role content-type="http://credit.niso.org/">Writing &#x2013; Review &amp; Editing</role>
                    <uri content-type="orcid">https://orcid.org/0000-0001-7952-4357</uri>
                    <xref ref-type="corresp" rid="c1">a</xref>
                    <xref ref-type="aff" rid="a1">1</xref>
                </contrib>
                <contrib contrib-type="author" corresp="no">
                    <name>
                        <surname>Ekasari</surname>
                        <given-names>Dhany Prafita</given-names>
                    </name>
                    <role content-type="http://credit.niso.org/">Conceptualization</role>
                    <role content-type="http://credit.niso.org/">Investigation</role>
                    <role content-type="http://credit.niso.org/">Methodology</role>
                    <role content-type="http://credit.niso.org/">Writing &#x2013; Original Draft Preparation</role>
                    <xref ref-type="aff" rid="a1">1</xref>
                </contrib>
                <contrib contrib-type="author" corresp="no">
                    <name>
                        <surname>Basuki</surname>
                        <given-names>Santosa</given-names>
                    </name>
                    <role content-type="http://credit.niso.org/">Methodology</role>
                    <role content-type="http://credit.niso.org/">Supervision</role>
                    <role content-type="http://credit.niso.org/">Visualization</role>
                    <role content-type="http://credit.niso.org/">Writing &#x2013; Review &amp; Editing</role>
                    <xref ref-type="aff" rid="a1">1</xref>
                </contrib>
                <contrib contrib-type="author" corresp="no">
                    <name>
                        <surname>Atif</surname>
                        <given-names>Muhammad Mazaya</given-names>
                    </name>
                    <role content-type="http://credit.niso.org/">Data Curation</role>
                    <role content-type="http://credit.niso.org/">Formal Analysis</role>
                    <role content-type="http://credit.niso.org/">Resources</role>
                    <role content-type="http://credit.niso.org/">Visualization</role>
                    <xref ref-type="aff" rid="a1">1</xref>
                </contrib>
                <contrib contrib-type="author" corresp="no">
                    <name>
                        <surname>Bhat M</surname>
                        <given-names>Ramesh</given-names>
                    </name>
                    <role content-type="http://credit.niso.org/">Formal Analysis</role>
                    <role content-type="http://credit.niso.org/">Supervision</role>
                    <role content-type="http://credit.niso.org/">Validation</role>
                    <role content-type="http://credit.niso.org/">Writing &#x2013; Review &amp; Editing</role>
                    <xref ref-type="aff" rid="a2">2</xref>
                </contrib>
                <aff id="a1">
                    <label>1</label>Department of Dermatology and Venereology, Faculty of Medicine,, Universitas Brawijaya /Dr. Saiful Anwar Regional General Hospital, Malang, East Java, 65111, Indonesia</aff>
                <aff id="a2">
                    <label>2</label>Professor, Department of Dermatology, Father Muller Medical College, Karnataka, India, 575002, India</aff>
            </contrib-group>
            <author-notes>
                <corresp id="c1">
                    <label>a</label>
                    <email xlink:href="mailto:dhelyawidasmara@ub.ac.id">dhelyawidasmara@ub.ac.id</email>
                </corresp>
                <fn fn-type="conflict">
                    <p>No competing interests were disclosed.</p>
                </fn>
            </author-notes>
            <pub-date pub-type="epub">
                <day>28</day>
                <month>9</month>
                <year>2022</year>
            </pub-date>
            <pub-date pub-type="collection">
                <year>2022</year>
            </pub-date>
            <volume>11</volume>
            <elocation-id>1117</elocation-id>
            <history>
                <date date-type="accepted">
                    <day>25</day>
                    <month>7</month>
                    <year>2022</year>
                </date>
            </history>
            <permissions>
                <copyright-statement>Copyright: &#x00a9; 2022 Widasmara D et al.</copyright-statement>
                <copyright-year>2022</copyright-year>
                <license xlink:href="https://creativecommons.org/licenses/by/4.0/">
                    <license-p>This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
                </license>
            </permissions>
            <self-uri content-type="pdf" xlink:href="https://f1000research.com/articles/11-1117/pdf"/>
            <abstract>
                <p>Background: Leprosy is a public health problem because it potentially affects social life. In 2018, World Health Organisation (WHO) reported that Indonesia ranks third of new cases leprosy. Leprosy significantly influences patients' quality of life. Until now, there is still no specific questionnaire to assess the quality of life for leprosy patients. Leprosy Quality of Life Questionnaire (KUKUH) is a questionnaire to assess leprosy patients' quality of life, which includes questions about psychology, physical health, social environment, and treatment. The study aimed to assess the validity and reliability of the Leprosy Quality of Life Questionnaire (KUKUH) as a tool to assess the quality of life of leprosy patients in Indonesia.</p>
                <p>Methods: The study was conducted at Saiful Anwar General Hospital in Malang, East Java. The validity analysis using construct validity with a minimum correlation coefficient value considered valid by 0.3. Internal consistency assessment for the questionnaire utilized the Cronbach &#x03b1; value where a value greater than or equal to 0.60 is acceptable, and a value greater than or equal to 0.80 is considered good.</p>
                <p>Results: Based on the result of variable validity test, all items measuring each aspect have item correlation coefficient values with a total score (riT) &gt; table correlation value (0.361). The results of reliability testing, the items that measure each aspect of the quality-of-life variable for leprosy patients have Cronbach's Alpha values greater than 0.6.</p>
                <p>Conclusion: The validity test results of KUKUH Questionnaire are considered quite good, with a total score of 0.361 for the correlation coefficient for each question in KUKUH. The reliability test results were deemed satisfactory, with Cronbach's alpha &gt; 0.6. The KUKUH questionnaire can be used to evaluate the quality of life of leprosy patients in Indonesia.</p>
            </abstract>
            <kwd-group kwd-group-type="author">
                <kwd>Leprosy</kwd>
                <kwd>Morbus Hansen</kwd>
                <kwd>Questionnaire</kwd>
                <kwd>Leprosy Quality of Life</kwd>
                <kwd>KUKUH</kwd>
            </kwd-group>
            <funding-group>
                <funding-statement>The author(s) declared that no grants were involved in supporting this work.</funding-statement>
            </funding-group>
        </article-meta>
    </front>
    <body>
        <sec id="sec1" sec-type="intro">
            <title>Introduction</title>
            <p>Chronic infectious disease that is caused by 
                <italic toggle="yes">Mycobacterium leprae</italic> is called Leprosy. This disease primarily affects the skin and peripheral nerves, resulting in sensory, motor, and autonomic dysfunction. 
                <italic toggle="yes">Mycobacterium leprae</italic> can be found in high concentrations on the nasal mucosa of leprosy patients. Bacilli can survive outside the body for 36 hours to nine days.
                <sup>
                    <xref ref-type="bibr" rid="ref1">1</xref>
                </sup> In 2019, 202,256 new cases of leprosy have been reported worldwide. India, Brazil, and Indonesia accounted for 79% of the most recent cases of leprosy patients globally.
                <sup>
                    <xref ref-type="bibr" rid="ref2">2</xref>
                </sup> At the end of 2018, the South-East Asia region (SEAR) accounted for 71% of new leprosy cases globally, with India and Indonesia accounting for 92% of the location's case load.
                <sup>
                    <xref ref-type="bibr" rid="ref3">3</xref>
                </sup>
            </p>
            <p>Leprosy is one of the infectious diseases that causes extremely complex problems, not only from a medical standpoint but also from a socioeconomic standpoint. The negative stigma from society persists, with people viewing leprosy as a frightening disease. Leprosy patients frequently experience psychosocial problems because of negative stigma.
                <sup>
                    <xref ref-type="bibr" rid="ref4">4</xref>
                </sup>
            </p>
            <p>Delay in diagnosis and treatment of leprosy patients can result in permanent damage to the peripheral nerves and possibly lead to amputation and disability, this can occur due to many factors such as lack of awareness, poor access to leprosy diagnosis and treatment, neglect, poverty, social stigma, etc. Even today, many patients are diagnosed with leprosy after they become disabled.
                <sup>
                    <xref ref-type="bibr" rid="ref5">5</xref>
                </sup>
            </p>
            <p>Leprosy can cause physical disability, which can have severe psychological consequences and will almost certainly reduce one's quality of life. Disability-related leprosy can cause economic, social, and psychological issues that have a negative impact on one's quality of life.
                <sup>
                    <xref ref-type="bibr" rid="ref6">6</xref>
                </sup>
            </p>
            <p>The study's findings also revealed that people with leprosy had lower mean quality of life scores than people without disabilities in all four domains of health relationships: physical, psychological, social, and environmental. Following this discovery, Tsutsumi 
                <italic toggle="yes">et al.</italic> (2007) and Dinesh 
                <italic toggle="yes">et al.</italic> (2016) discovered that people suffering from leprosy have a low quality of life.
                <sup>
                    <xref ref-type="bibr" rid="ref6">6</xref>
                </sup>
                <sup>&#x2013;</sup>
                <sup>
                    <xref ref-type="bibr" rid="ref8">8</xref>
                </sup> A 2015 study in Brazil with 106 leprosy patients found a lower quality of life, particularly in leprosy patients with disabilities. Disability was associated with a decrease in quality of life (p = 0.001).
                <sup>
                    <xref ref-type="bibr" rid="ref9">9</xref>
                </sup>
            </p>
            <p>The European Academy of Dermatology and Venereology (EADV) believes that measuring quality of life in clinical practice can benefit patients, support physician decision-making, and contribute to the delivery of high-quality care. The goal of this Statement is to describe the various ways in which using quality of life measures can be beneficial in clinical practice.
                <sup>
                    <xref ref-type="bibr" rid="ref10">10</xref>
                </sup>
            </p>
            <p>Data on quality of life can aid in therapeutic strategy decisions and encourage patient participation in joint decision-making with doctors. Patients' understanding of non-medical aspects of their illness supplements the physician's knowledge of medical factors. Medication adjustments can be made while viewing the patient's quality of life data, which can aid in clinical decisions such as dose adjustments and changes to follow-up therapy.
                <sup>
                    <xref ref-type="bibr" rid="ref11">11</xref>
                </sup>
            </p>
            <p>Leprosy can cause paralysis and deformity, which can lead to social stigma and exclusion, negatively impacting patients' quality of life.
                <sup>
                    <xref ref-type="bibr" rid="ref12">12</xref>
                </sup> There is currently no specific quality of life assessment questionnaire available to assess the quality of life of leprosy patients. Information about people with leprosy's quality of life is expected to be the foundation for overcoming the problem of leprosy, which focuses not only on the physical but also on other factors that may lead to a decrease in the quality of life of people with leprosy.</p>
            <p>Leprosy Quality of Life (KUKUH) is a questionnaire that can be filled out by patients to assess the leprosy patients&#x2019; quality of life. It consists of ten questions on one sheet of paper and includes questions about aspects of psychology, physical health, social environment, and treatment. The Total Leprosy Quality of Life Score (KUKUH) is calculated by adding the scores for each question. Each question's score has its own interpretation. KUKUH is a short and simple acronym that can be used in clinical practice and research. The Leprosy Quality of Life (KUKUH) questionnaire must be tested for validity and reliability before it can be used in the Indonesian leprosy population. The goal of this study was to determine the validity and reliability of the Leprosy Quality of Life Questionnaire (KUKUH) so that it could be used widely in Indonesian leprosy patients. Among the various types of validity, the construct validity is the most used for various types of research to test the validity of the questionnaire. The external validity test, which correlated a questionnaire with a valid measuring instrument, was not performed because there was no gold standard questionnaire for assessing the quality of life of leprosy patients in Indonesian. As a result, in this study, the construction validity is evaluated to assess the validity of all questions in the Leprosy Quality of Life (KUKUH) questionnaire. The instrument was tested for reliability with an internal consistency test on the research subject once. The Cronbach Alpha technique can be used to perform this test.</p>
        </sec>
        <sec id="sec2" sec-type="methods">
            <title>Methods</title>
            <sec id="sec3">
                <title>Research design</title>
                <p>The research design tested the validity and reliability of the Leprosy Quality of Life Questionnaire (KUKUH) using a cross-sectional study design.</p>
                <p>Patients diagnosed with leprosy/Morbus Hansen with the type of Pausibacillary and Multibacillary with a degree of disability 0-2 were controlled at the Dermatology and Venereology Polyclinic, Saiful Anwar Regional General Hospital, and at the Primary Public Health Center, Malang East Java. The sample size is 30 people.</p>
                <p>The inclusion criteria were that patients had to be between the ages of 18 and 60, have a clinical diagnosis of leprosy, be able to communicate in Indonesian, read, and be willing to participate in research by signing informed consent. Patients with psychiatric disorders were excluded from the study.</p>
                <p>The researchers recorded the identity, diagnosis of leprosy type, and the degree of disability of patients who had signed the consent form. Research subjects were asked to fill out the Quality-of-Life Leprosy (KUKUH) Questionnaire after receiving an explanation on how to fill out the questionnaire. The research subjects filled out the questionnaires themselves, but the researchers accompanied the process of filling out the questionnaires to provide explanations if needed.</p>
                <p>Using the Pearson product-moment correlation technique formula, validity analysis uses construction validity by calculating the correlation between each statement and the total score. The minimum correlation coefficient value that is considered valid is 0.3. Correlation numbers below the minimum value indicate an invalid argument, perhaps due to the arrangement of words or sentences that are not good, or the sentences give different interpretations that require evaluation. The corrected statement must be tested again for validity on a diverse sample until valid results are obtained.</p>
                <p>Internal consistency is used to test the reliability of the Leprosy Quality of Life (KUKUH) Questionnaire. Internal consistency is assessed using the Cronbach value, a value greater than 0.60 is acceptable, and a value greater than 0.80 is considered good.</p>
                <p>The data is recorded in a particular format then edited and coded. The data was entered in the SPSS worksheet and then processed using the SPSS v. 21 program. Univariate analysis was to determine the distribution of the characteristics of the research subjects. The construction validity assessment uses Pearson's product-moment correlation technique to see the correlation value between each statement and the total score. Internal consistency is used to test the reliability of the Leprosy Quality of Life (KUKUH) Questionnaire
                    <sup>
                        <xref ref-type="bibr" rid="ref18">18</xref>
                    </sup> and is assessed using the Cronbach &#x03b1; value.</p>
            </sec>
        </sec>
        <sec id="sec4" sec-type="results">
            <title>Results</title>
            <p>The Pearson Correlation (Product Moment) technique was used to test the instrument's validity by correlating each score in each item with the total score. The Pearson Correlation technique test criteria state that if the correlation coefficient (riT) table correlation (rtable) is greater than one, the questionnaire item is declared valid or capable of measuring variables and can be used as a data collection tool.</p>
            <p>Based on the results of validity test of the research variables (
                <xref ref-type="table" rid="T1">Table 1</xref>), all items which measuring each aspect, have coefficient correlation values with a total score (riT) &gt; table correlation value (0.361). As a result, the questionnaire items that measure every aspect of leprosy patients' quality of life are declared valid or capable of measuring these variables and will be used as a data collection tool in this study.</p>
            <table-wrap id="T1" orientation="portrait" position="float">
                <label>Table 1. </label>
                <caption>
                    <title>Validity test instrument.</title>
                </caption>
                <table content-type="article-table" frame="hsides">
                    <thead>
                        <tr>
                            <th align="left" colspan="1" rowspan="1" valign="top">Variable</th>
                            <th align="left" colspan="1" rowspan="1" valign="top">Aspect</th>
                            <th align="left" colspan="1" rowspan="1" valign="top">Item</th>
                            <th align="left" colspan="1" rowspan="1" valign="top">Correlation Coefficient</th>
                            <th align="left" colspan="1" rowspan="1" valign="top">Description</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td align="left" colspan="1" rowspan="10" valign="middle">Quality of Life for Leprosy Patients</td>
                            <td align="left" colspan="1" rowspan="4" valign="middle">Psychology</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">Item 1</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">0.871</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">Valid</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="middle">Item 2</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">0.945</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">Valid</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="middle">Item 3</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">0.909</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">Valid</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="middle">Item 4</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">0.722</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">Valid</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="3" valign="middle">Physical Health</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">Item 5</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">0.913</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">Valid</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="middle">Item 6</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">0.820</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">Valid</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="middle">Item 7</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">0.794</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">Valid</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="middle">Social and Environment</td>
                            <td align="left" colspan="1" rowspan="1" valign="bottom">Item 8</td>
                            <td align="left" colspan="1" rowspan="1" valign="bottom">1.000</td>
                            <td align="left" colspan="1" rowspan="1" valign="bottom">Valid</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="2" valign="middle">Treatment</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">Item 9</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">0.937</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">Valid</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="middle">Item 10</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">0.914</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">Valid</td>
                        </tr>
                    </tbody>
                </table>
            </table-wrap>
            <p>According to a summary of the research instrument's reliability testing results (
                <xref ref-type="table" rid="T2">Table 2</xref>), the items that measure every aspect of the quality-of-life variable for leprosy patients have Cronbach's Alpha values greater than 0.6. As a result, the questionnaire items that measure every aspect of leprosy patients' quality of life have been declared reliable or consistent in measuring these variables and will be used as a data collection tool in this study.</p>
            <table-wrap id="T2" orientation="portrait" position="float">
                <label>Table 2. </label>
                <caption>
                    <title>Reliability test instrument.</title>
                </caption>
                <table content-type="article-table" frame="hsides">
                    <thead>
                        <tr>
                            <th align="left" colspan="1" rowspan="1" valign="top">Variable</th>
                            <th align="left" colspan="1" rowspan="1" valign="top">Aspect</th>
                            <th align="left" colspan="1" rowspan="1" valign="top">Cronbach's Alpha</th>
                            <th align="left" colspan="1" rowspan="1" valign="top">Description</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td align="left" colspan="1" rowspan="4" valign="middle">Quality of Life for Leprosy Patients</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">Psychology</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">0.885</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">Reliable</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="middle">Physical Health</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">0.790</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">Reliable</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="middle">Social and Environment</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">1.000</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">Reliable</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="middle">Treatment</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">0.828</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">Reliable</td>
                        </tr>
                    </tbody>
                </table>
            </table-wrap>
            <p>Based on the summary of the correlation coefficient and the value of Cronbach's alpha in each aspect (
                <xref ref-type="table" rid="T3">Table 3</xref>), the average value of the correlation coefficient in the psychological aspect is 0.862, and the value of Cronbach's alpha is 0.885. Then, the average value of the correlation coefficient on the physical health aspect is 0.843, and Cronbach's alpha value is 0.790. Furthermore, the average value of the correlation coefficient on social and environmental aspects is 1.000, Cronbach's alpha value is 1.000, and the average value of the correlation coefficient on the treatment aspect is 0.926, and Cronbach's alpha value is 0.828.</p>
            <table-wrap id="T3" orientation="portrait" position="float">
                <label>Table 3. </label>
                <caption>
                    <title>Correlation coefficient and Cronbach&#x2019;s alpha value.</title>
                </caption>
                <table content-type="article-table" frame="hsides">
                    <thead>
                        <tr>
                            <th align="left" colspan="1" rowspan="1" valign="top">Aspect</th>
                            <th align="left" colspan="1" rowspan="1" valign="top">Correlation Coefficient</th>
                            <th align="left" colspan="1" rowspan="1" valign="top">Cronbach's Alpha</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="middle">Psychology</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">0.862</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">0.885</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="middle">Physical Health</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">0.843</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">0.790</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="middle">Social and Environment</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">1.000</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">1.000</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="middle">Treatment</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">0.926</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">0.828</td>
                        </tr>
                    </tbody>
                </table>
            </table-wrap>
        </sec>
        <sec id="sec5" sec-type="discussion">
            <title>Discussion</title>
            <p>Data on quality of life can help with therapeutic strategy decisions and encourage patient involvement in decision making. Patients' understanding of non-medical aspects of their illness supplements the physician's knowledge of medical factors. Medication adjustments made while viewing patient quality of life data can assist physicians in clinical decisions such as dose adjustments or changes to follow-up therapy, for example, to reduce the identified quality of life impacts more quickly. The treatment's effect can also have an impact on the quality-of-life score.
                <sup>
                    <xref ref-type="bibr" rid="ref11">11</xref>
                </sup>
            </p>
            <p>Regular quality of life measurements can aid in monitoring the progression of a condition or the efficacy of therapy. Changes in the score can be instructive and serve as a reminder to the doctor to reconsider changing treatment. For many patients and doctors, the most important outcome of care is improved quality of life. Quality of life measurement can be used as a screening tool to uncover &#x201c;hidden&#x201d; physical, psychological, and adjustment issues, as well as to identify patients who may need to be referred to other specialists or who may require additional support or care.
                <sup>
                    <xref ref-type="bibr" rid="ref11">11</xref>
                </sup>
            </p>
            <p>Health questionnaires are generally designed to detect a psychological disorder and are reliable in dermatology patients. Quality of life measurement can show the effect of skin disease compared to other organ diseases.
                <sup>
                    <xref ref-type="bibr" rid="ref11">11</xref>
                </sup>
            </p>
            <p>The European Academy of Dermatology and Venereology (EADV) summarizes at least 40 tools for measuring the quality of life and health status for skin diseases. Quality of life in dermatology is most often assessed with generic and specialized instruments for dermatology-specific conditions. Researchers and clinicians have a wide choice of tools in which several parameters can influence therapy for a patient. Doctors and patients prefer short instruments and a short time to complete them. Another critical parameter in assessing the quality of life is validation. A well-validated tool has a better chance of being widely used.
                <sup>
                    <xref ref-type="bibr" rid="ref13">13</xref>
                </sup>
            </p>
            <p>An excellent measuring instrument or instrument must meet the requirements for testing its validity and reliability. Validity in the context of research instruments means that the validity of a study is related to the extent to which a researcher measures what is supposed to be measured. Moreover, the validity of quantitative research is rooted in empiricism, which emphasizes evidence, objectivity, truth, deduction, reason, facts, and numerical data. The measurement tools commonly used are questionnaires and tests. In this context, the questionnaire measuring instrument needs to be structured in such a way that it can be used as the right instrument to obtain, find, describe, explore, and compare various information, topics, and research variables.
                <sup>
                    <xref ref-type="bibr" rid="ref11">11</xref>
                </sup> Construction validity relates to whether the research tools have been prepared based on an appropriate and relevant theoretical construct. Questionnaires with high construct validity are always based on the definition or limitations of experts on the concept, not on a dictionary definition. Based on these limitations, researchers can arrange appropriate statements and questions. With SPSS, questionnaires and test items need to be measured using factor analysis.
                <sup>
                    <xref ref-type="bibr" rid="ref14">14</xref>
                </sup>
            </p>
            <p>Construct validity focuses on the extent to which a measuring instrument shows measurement results that conform to its definition. The definition of variables must be clear to facilitate the assessment of construct validity. The definition is derived from theory. If the definition is based on the correct theory and the question or item statement is appropriate, then the instrument is declared valid with construction validity.
                <sup>
                    <xref ref-type="bibr" rid="ref15">15</xref>
                </sup>
            </p>
            <p>Using the Pearson product-moment correlation technique formula, validity analysis uses construction validity by calculating the correlation between each statement and the total score. The minimum correlation coefficient value that is considered valid is 0.3. Correlation numbers below the minimum value indicate an invalid statement, perhaps due to the arrangement of words or sentences that are not good, or the sentences give different interpretations that require evaluation. The corrected statement must be tested again for validity on a diverse sample until valid results are obtained.
                <sup>
                    <xref ref-type="bibr" rid="ref16">16</xref>
                </sup>
            </p>
            <p>According to the results of testing the validity of this research variable, all items measuring each aspect have item correlation coefficient values with a total score (riT) greater than the table correlation value (0.361). As a result, the questionnaire items that measure every aspect of the quality-of-life variable of leprosy patients are declared valid or capable of measuring these variables, and will be used as a data collection tool in this study.</p>
            <p>Trustworthiness, reliability, constancy, stability, and consistency are all synonyms for reliability. The main idea behind the concept of reliability is "the degree to which measurement results can be trusted." The term reliability refers to the degree to which measurement results can be trusted. Furthermore, the concept of reliability refers to the consistency of the scores on the questionnaire items, so that the reliability test evaluates the accuracy of the research instrument's measurement scales.
                <sup>
                    <xref ref-type="bibr" rid="ref14">14</xref>
                </sup>
            </p>
            <p>Therefore, the main purpose of testing the reliability of research instruments is to measure the consistency of the measuring instruments used by quantitative researchers. In this context, the researcher wants to determine whether there is the accuracy of measurement results in the same sample at different times. A research instrument, such as a questionnaire, is reliable if it can provide consistent scores on each measurement. Then the measurement tool (items of statements/questions) still provides consistent measurement results at different times.
                <sup>
                    <xref ref-type="bibr" rid="ref14">14</xref>
                </sup>
            </p>
            <p>Re-measurement techniques, halving techniques, parallel techniques, and internal consistency can all be used to calculate reliability. Only questions with existing validity should be subjected to reliability calculations (Rahmatina, 2013). If the Cronbach's Alpha reliability coefficient is greater than 0.70 (ri &gt; 0.70), the instrument is said to be reliable, and if the Cronbach's Alpha reliability coefficient is greater than 0.90 (ri 0.9), the instrument is said to be unreliable. Tavakol and Dennick (2011) recommend revising or eliminating items with low correlations if the Cronbach's Alpha reliability coefficient is less than 0.70 (ri 0.70).
                <sup>
                    <xref ref-type="bibr" rid="ref17">17</xref>
                </sup> A computer program can be used to quickly determine the object of the question. They also have suggestions if the Cronbach's Alfa reliability coefficient is greater than 0.90 (ri &gt; 0.90). They advocate for fewer questions with the same criteria, even if they are in different sentences.
                <sup>
                    <xref ref-type="bibr" rid="ref15">15</xref>
                </sup>
            </p>
            <p>According to a summary of the research instrument's reliability testing results, the items that measure each aspect of the quality-of-life variable for leprosy patients have Cronbach's Alpha values greater than 0.6. As a result, the questionnaire items that measure every aspect of leprosy patients' variable quality of life are declared reliable or consistent in measuring these variables, allowing them to be used as data collection tools.</p>
        </sec>
        <sec id="sec6" sec-type="conclusion">
            <title>Conclusion</title>
            <p>The validity test results of the Indonesian language KUKUH Questionnaire to assess the quality of life of leprosy patients were considered good, with a total score of 0.361 for the correlation coefficient for each question. The reliability test results were deemed satisfactory, with Cronbach's alpha &gt; 0.6. The KUKUH questionnaire can be used to evaluate the quality of life of leprosy patients in Indonesia.</p>
        </sec>
        <sec id="sec8">
            <title>Data availability</title>
            <sec id="sec9">
                <title>Underlying data</title>
                <p>Zenodo: The validity and reliability test of the leprosy life quality questionnaire in leprosy patients.
                    <sup>
                        <xref ref-type="bibr" rid="ref18">18</xref>
                    </sup>
                </p>
                <p>
                    <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.5281/zenodo.6817556">https://doi.org/10.5281/zenodo.6817556</ext-link>
                </p>
                <p>This project contains the following underlying data:
                    <list list-type="bullet">
                        <list-item>
                            <label>&#x2010;</label>
                            <p>Analytic Data Revised/Raw Data.xlsx</p>
                        </list-item>
                        <list-item>
                            <label>&#x2010;</label>
                            <p>Validity and Reliability Test Result.docx</p>
                        </list-item>
                        <list-item>
                            <label>&#x2010;</label>
                            <p>Validity and reliability test.sav</p>
                        </list-item>
                    </list>
                </p>
                <p>This project contains the following extended data:
                    <list list-type="bullet">
                        <list-item>
                            <label>&#x2010;</label>
                            <p>Quality of Life Questionnaire (KUKUH).docx</p>
                        </list-item>
                    </list>
                </p>
                <p>Data are available under the terms of the 
                    <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution 4.0 International license</ext-link> (CC-BY 4.0).</p>
            </sec>
        </sec>
    </body>
    <back>
        <ref-list>
            <title>References</title>
            <ref id="ref1">
                <label>1</label>
                <mixed-citation publication-type="book">
                    <person-group person-group-type="editor">

                        <name name-style="western">
                            <surname>Widasmara</surname>
                            <given-names>D</given-names>
                        </name>
</person-group>:
                    <source>

                        <italic toggle="yes">Leprosy A Clinical Perspective.</italic>
</source>
                    <publisher-loc>Poor. Malang</publisher-loc>:
                    <publisher-name>UB Press</publisher-name>;
                    <edition>first ed</edition>
                    <year>2018</year>.</mixed-citation>
            </ref>
            <ref id="ref2">
                <label>2</label>
                <mixed-citation publication-type="other">
                    <collab>World Health Organization</collab>:
                    <article-title>Towards zero leprosies. Global leprosy (Hansen's Disease) strategy 2021&#x2013;2030.</article-title>
                    <year>2021</year>.</mixed-citation>
            </ref>
            <ref id="ref3">
                <label>3</label>
                <mixed-citation publication-type="other">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Sardana</surname>
                            <given-names>K</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Khurana</surname>
                            <given-names>A</given-names>
                        </name>
</person-group>:
                    <source>

                        <italic toggle="yes">Epidemiology and World Distribution, Handbook Of Leprosy.</italic>
</source>
                    <edition>6th ed.</edition>
                    <year>2020</year>; vol. 1:<fpage>4</fpage>&#x2013;<lpage>5</lpage>.</mixed-citation>
            </ref>
            <ref id="ref4">
                <label>4</label>
                <mixed-citation publication-type="book">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Azizah</surname>
                            <given-names>N</given-names>
                        </name>
</person-group>:
                    <source>

                        <italic toggle="yes">Analysis of the Impact of Leprosy on the Social Interaction of Patients in Brondong, Lamongan.</italic>
</source>
                    <publisher-loc>Statistics Paper ITS</publisher-loc>:
                    <publisher-name>Indonesia</publisher-name>;<year>2011</year>.</mixed-citation>
            </ref>
            <ref id="ref5">
                <label>5</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Nery</surname>
                            <given-names>R</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Ramond</surname>
                            <given-names>A</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Pescarini</surname>
                            <given-names>JM</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Socioeconomic determinants of leprosy new case detection in the 100 Million Brazilian Cohort: a population-based linkage study.</article-title>
                    <source>

                        <italic toggle="yes">Lancet Glob. Health.</italic>
</source>
                    <year>2019</year>;<volume>7</volume>(<issue>9</issue>):<fpage>e1226</fpage>&#x2013;<lpage>e1236</lpage>.
                    <pub-id pub-id-type="pmid">31331811</pub-id>
                    <pub-id pub-id-type="doi">10.1016/S2214-109X(19)30260-8</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref6">
                <label>6</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Govindharaj</surname>
                            <given-names>P</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Srinivasan</surname>
                            <given-names>S</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Darlong</surname>
                            <given-names>J</given-names>
                        </name>
</person-group>:
                    <article-title>Quality of life of persons affected by leprosy in an endemic district, West Bengal, India.</article-title>
                    <source>

                        <italic toggle="yes">Indian J. Dermatol.</italic>
</source>
                    <year>2018</year>;<volume>63</volume>(<issue>6</issue>):<fpage>459</fpage>&#x2013;<lpage>464</lpage>.
                    <pub-id pub-id-type="pmid">30504972</pub-id>
                    <pub-id pub-id-type="doi">10.4103/ijd.IJD_324_18</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref7">
                <label>7</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Tsutsumi</surname>
                            <given-names>A</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Izutsu</surname>
                            <given-names>T</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Islam</surname>
                            <given-names>AM</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>The quality of life, mental health, and perceived stigma of leprosy patients in Bangladesh.</article-title>
                    <source>

                        <italic toggle="yes">Soc. Sci. Med.</italic>
</source>
                    <year>2007</year>;<volume>64</volume>(<issue>12</issue>):<fpage>2443</fpage>&#x2013;<lpage>2453</lpage>.
                    <pub-id pub-id-type="pmid">17382441</pub-id>
                    <pub-id pub-id-type="doi">10.1016/j.socscimed.2007.02.014</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref8">
                <label>8</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Dinesh</surname>
                            <given-names>G</given-names>
                        </name>

                        <name name-style="western">
                            <surname>John</surname>
                            <given-names>KR</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Logaraj</surname>
                            <given-names>M</given-names>
                        </name>
</person-group>:
                    <article-title>An assessment of quality of life among leprosy affected persons residing in leprosy settlements of Chengalpet Taluk, Kancheepuram, Tamil Nadu.</article-title>
                    <source>

                        <italic toggle="yes">Natl. J. Res. Community Med.</italic>
</source>
                    <year>2016</year>;<volume>5</volume>:<fpage>149</fpage>&#x2013;<lpage>154</lpage>.</mixed-citation>
            </ref>
            <ref id="ref9">
                <label>9</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Santos</surname>
                            <given-names>VS</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Oliveira</surname>
                            <given-names>LS</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Castro</surname>
                            <given-names>FD</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Functional activity limitation and quality of life of leprosy cases in an endemic area in Northeastern Brazil.</article-title>
                    <source>

                        <italic toggle="yes">PLoS Negl. Trop. Dis.</italic>
</source>
                    <year>2015</year>;<volume>9</volume>(<issue>7</issue>):<fpage>e0003900</fpage>.
                    <pub-id pub-id-type="doi">10.1371/journal.pntd.0003900</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref10">
                <label>10</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Mokkink</surname>
                            <given-names>LB</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Terwee</surname>
                            <given-names>CB</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Patrick</surname>
                            <given-names>DL</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>The COSMIN checklist for assess-ing the methodological quality of studies on measurement properties of health status measurement instruments: an international Delphi study.</article-title>
                    <source>

                        <italic toggle="yes">Qual. Life Res.</italic>
</source>
                    <year>2010</year>;<volume>19</volume>:<fpage>539</fpage>&#x2013;<lpage>549</lpage>.
                    <pub-id pub-id-type="pmid">20169472</pub-id>
                    <pub-id pub-id-type="doi">10.1007/s11136-010-9606-8</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref11">
                <label>11</label>
                <mixed-citation publication-type="other">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Finlay</surname>
                            <given-names>AY</given-names>
                        </name>
</person-group>
                    <article-title>Principles of measurement and assessment in dermatology. Rook's Textbook of Dermatology, Ninth Edition.</article-title>
                    <year>2016</year>;<fpage>1</fpage>&#x2013;<lpage>13</lpage>.</mixed-citation>
            </ref>
            <ref id="ref12">
                <label>12</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>El-Refaei</surname>
                            <given-names>A</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Health Related Quality of Life in Egyptian Leprosy Patients using DLQ and WHOQOL-BREF Questionnaires.</article-title>
                    <source>

                        <italic toggle="yes">J. Clin. Exp. Dermatol. Res.</italic>
</source>
                    <year>2018</year>;<volume>9</volume>:<fpage>475</fpage>.</mixed-citation>
            </ref>
            <ref id="ref13">
                <label>13</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Chernyshov</surname>
                            <given-names>PV</given-names>
                        </name>
</person-group>:
                    <article-title>The evolution of quality of life assessment and use in dermatology.</article-title>
                    <source>

                        <italic toggle="yes">Dermatology.</italic>
</source>
                    <year>2019</year>;<volume>235</volume>(<issue>3</issue>):<fpage>167</fpage>&#x2013;<lpage>174</lpage>.
                    <pub-id pub-id-type="pmid">30928986</pub-id>
                    <pub-id pub-id-type="doi">10.1159/000496923</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref14">
                <label>14</label>
                <mixed-citation publication-type="book">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Budiastuti</surname>
                            <given-names>D</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Bandur</surname>
                            <given-names>A</given-names>
                        </name>
</person-group>:
                    <source>

                        <italic toggle="yes">Research validity and reliability. Equipped with Data Analysis using NVivo, SPSS, and AMOS.</italic>
</source>
                    <publisher-loc>Jakarta</publisher-loc>:
                    <publisher-name>Mitra Wacana Media</publisher-name>;<year>2018</year>.</mixed-citation>
            </ref>
            <ref id="ref15">
                <label>15</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Yusup</surname>
                            <given-names>F</given-names>
                        </name>
</person-group>:
                    <article-title>Test the validity and reliability of quantitative research instruments.</article-title>
                    <source>

                        <italic toggle="yes"> Tarbiyah: Scientific. J. Educ.</italic>
</source>
                    <year>2018</year>;<volume>7</volume>(<issue>1</issue>).</mixed-citation>
            </ref>
            <ref id="ref16">
                <label>16</label>
                <mixed-citation publication-type="book">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Notoatmodjo</surname>
                            <given-names>S</given-names>
                        </name>
</person-group>:
                    <source>

                        <italic toggle="yes">Develop research instruments. Medical research methodology.</italic>
</source>
                    <publisher-loc>Jakarta</publisher-loc>:
                    <publisher-name>Rineka Cipta</publisher-name>;<year>2010</year>;<fpage>152</fpage>&#x2013;<lpage>170</lpage>.</mixed-citation>
            </ref>
            <ref id="ref17">
                <label>17</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Tavakol</surname>
                            <given-names>M</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Dennick</surname>
                            <given-names>R</given-names>
                        </name>
</person-group>:
                    <article-title>Making sense of Cronbach&#x2019;s alpha.</article-title>
                    <source>

                        <italic toggle="yes">Int. J. Med. Educ.</italic>
</source>
                    <year>2011 Jun</year>;<volume>27</volume>(<issue>2</issue>):<fpage>53</fpage>&#x2013;<lpage>55</lpage>.
                    <pub-id pub-id-type="pmid">28029643</pub-id>
                    <pub-id pub-id-type="doi">10.5116/ijme.4dfb.8dfd</pub-id>
                    <pub-id pub-id-type="pmcid">PMC4205511</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref18">
                <label>18</label>
                <mixed-citation publication-type="other">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Widasmara</surname>
                            <given-names>D</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>&#x2018;The validity and reliability test of the leprosy life quality questionnaire in leprosy patients&#x2019; [Data].</article-title>
                    <year>2022</year>.
                    <pub-id pub-id-type="doi">10.5281/ZENODO.6817556</pub-id>
                </mixed-citation>
            </ref>
        </ref-list>
    </back>
    <sub-article article-type="reviewer-report" id="report210839">
        <front-stub>
            <article-id pub-id-type="doi">10.5256/f1000research.121556.r210839</article-id>
            <title-group>
                <article-title>Reviewer response for version 1</article-title>
            </title-group>
            <contrib-group>
                <contrib contrib-type="author">
                    <name>
                        <surname>Ong'ang'o</surname>
                        <given-names>Jane Rahedi</given-names>
                    </name>
                    <xref ref-type="aff" rid="r210839a1">1</xref>
                    <role>Referee</role>
                    <uri content-type="orcid">https://orcid.org/0000-0001-5481-8447</uri>
                </contrib>
                <aff id="r210839a1">
                    <label>1</label>Centre for Respiratory Diseases, Kenya Medical Research Institute, Nairobi, Kenya</aff>
            </contrib-group>
            <author-notes>
                <fn fn-type="conflict">
                    <p>
                        <bold>Competing interests: </bold>No competing interests were disclosed.</p>
                </fn>
            </author-notes>
            <pub-date pub-type="epub">
                <day>17</day>
                <month>11</month>
                <year>2023</year>
            </pub-date>
            <permissions>
                <copyright-statement>Copyright: &#x00a9; 2023 Ong'ang'o JR</copyright-statement>
                <copyright-year>2023</copyright-year>
                <license xlink:href="https://creativecommons.org/licenses/by/4.0/">
                    <license-p>This is an open access peer review report distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
                </license>
            </permissions>
            <related-article ext-link-type="doi" id="relatedArticleReport210839" related-article-type="peer-reviewed-article" xlink:href="10.12688/f1000research.109992.1"/>
            <custom-meta-group>
                <custom-meta>
                    <meta-name>recommendation</meta-name>
                    <meta-value>approve-with-reservations</meta-value>
                </custom-meta>
            </custom-meta-group>
        </front-stub>
        <body>
            <p>The tool for validation is based on the concept of QoL and includes physical activity, psychological condition, environment and social relationship and treatment.</p>
            <p> </p>
            <p> To understand whether this tool was a comprehensive evaluation of different aspects of QoL, it would be important to indicate what were the details/questions of the different QoL domains for a reader to assess the appropriateness. Under the section of data availability the questionnaire is available but I did not have access to enable me review it.</p>
            <p> </p>
            <p> Was there any reference to the use of other instruments for assessing quality of life eg the WHOQOL-bref tool, the short form-36 (SF-36), the Dermatology life of quality index (DLQI)?</p>
            <p> In developing this tool, it would be important to understand this if at all as part of tool development.</p>
            <p> </p>
            <p> </p>
            <p> A mention of limitations of the tool may be important. For example this may apply to this tool or not; considering the quantitative data on QoL may only reflect the multidisciplinary nature of the domains of focus but may not capture their subjectivity so the inclusion of qualitative approaches may be important to understand the experience and needs of patients in specific contexts. Another limitation is that the validation is only limited to one language of Indonesia and for one to participate in using the tool they had to be able to read and write the language. The tool was self administered. This may limit response especially if the question is not well understood.</p>
            <p> </p>
            <p> What was the criteria to select the group of individuals that participated in the validation age 18-60 years? Was the stage of disease considered; a patient with advanced stage of disease could lead to bias on scores of poor QoL. Excluding children/their guardians to participate may miss out a specific context in relation to children/adolescents.</p>
            <p> </p>
            <p> In the discussion section it is stated that if the Cronbach's Alpha reliability coefficient is greater than 0.70 (ri &gt; 0.70), the instrument is said to be reliable, and if the Cronbach's Alpha reliability coefficient is greater than 0.90 (ri 0.9), the instrument is said to be unreliable.&#x00a0;This needs to be consistent with what is indicated in the methods section that with Cronbach's alpha &gt; 0.6 the instrument is reliable.</p>
            <p>Is the work clearly and accurately presented and does it cite the current literature?</p>
            <p>Partly</p>
            <p>If applicable, is the statistical analysis and its interpretation appropriate?</p>
            <p>Yes</p>
            <p>Are all the source data underlying the results available to ensure full reproducibility?</p>
            <p>Yes</p>
            <p>Is the study design appropriate and is the work technically sound?</p>
            <p>Partly</p>
            <p>Are the conclusions drawn adequately supported by the results?</p>
            <p>Partly</p>
            <p>Are sufficient details of methods and analysis provided to allow replication by others?</p>
            <p>Partly</p>
            <p>Reviewer Expertise:</p>
            <p>Public health research and health systems strengthening research for both communicable and non-communicable health conditions.</p>
            <p>I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard, however I have significant reservations, as outlined above.</p>
        </body>
    </sub-article>
    <sub-article article-type="reviewer-report" id="report210830">
        <front-stub>
            <article-id pub-id-type="doi">10.5256/f1000research.121556.r210830</article-id>
            <title-group>
                <article-title>Reviewer response for version 1</article-title>
            </title-group>
            <contrib-group>
                <contrib contrib-type="author">
                    <name>
                        <surname>Govindharaj</surname>
                        <given-names>Pitchaimani</given-names>
                    </name>
                    <xref ref-type="aff" rid="r210830a1">1</xref>
                    <role>Referee</role>
                    <uri content-type="orcid">https://orcid.org/0000-0002-3637-3760</uri>
                </contrib>
                <aff id="r210830a1">
                    <label>1</label>Allied Health Sciences, Sri Ramachandra Institute of Higher Education and Research (Deemed to be University), Chennai, Tamil Nadu, India</aff>
            </contrib-group>
            <author-notes>
                <fn fn-type="conflict">
                    <p>
                        <bold>Competing interests: </bold>No competing interests were disclosed.</p>
                </fn>
            </author-notes>
            <pub-date pub-type="epub">
                <day>17</day>
                <month>11</month>
                <year>2023</year>
            </pub-date>
            <permissions>
                <copyright-statement>Copyright: &#x00a9; 2023 Govindharaj P</copyright-statement>
                <copyright-year>2023</copyright-year>
                <license xlink:href="https://creativecommons.org/licenses/by/4.0/">
                    <license-p>This is an open access peer review report distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
                </license>
            </permissions>
            <related-article ext-link-type="doi" id="relatedArticleReport210830" related-article-type="peer-reviewed-article" xlink:href="10.12688/f1000research.109992.1"/>
            <custom-meta-group>
                <custom-meta>
                    <meta-name>recommendation</meta-name>
                    <meta-value>approve-with-reservations</meta-value>
                </custom-meta>
            </custom-meta-group>
        </front-stub>
        <body>
            <p>First, I appreciate the authors for developing the Leprosy Quality of Life Questionnaire (KUKUH) to assess the quality of life of patients with leprosy in Indonesia. However, there are several areas of concern that need to be addressed before the paper can be indexed. 
                <list list-type="bullet">
                    <list-item>
                        <p>It would be good if you changed the word to &#x2018;people affected by leprosy&#x2019; instead of &#x2018;leprosy patient&#x2019;.</p>
                    </list-item>
                    <list-item>
                        <p>The authors should provide the process of questionnaire development, such as identification of the domains and item generation. The authors do not consider content validity (theoretical analysis). Content validity is mainly assessed through evaluation by expert and target population judges.</p>
                    </list-item>
                    <list-item>
                        <p>Items: How many items were collected? How was the process of item selection done? What criteria were used for item reduction?&#x00a0;</p>
                    </list-item>
                    <list-item>
                        <p>Pre-testing of the questionnaire is one of the processes of testing the measurement tools, and this process is missing in this study.</p>
                    </list-item>
                    <list-item>
                        <p>Sample Size: The rule of thumb has been at least 10 participants for each scale item, i.e., an ideal ratio of respondents to items is 10:1. The small sample size is inadequate to draw a conclusion.</p>
                    </list-item>
                    <list-item>
                        <p>This questionnaire includes domains of psychology, physical health, social environment, and treatment. The authors merely placed the items in the domains; no factor analysis was done to explore the domains. Furthermore, for a domain to be considered, a minimum of three items are required. In this questionnaire, only one item is present in the social and environmental domains, and two items are in the treatment domain.</p>
                    </list-item>
                    <list-item>
                        <p>There is inconsistency in the description of the Cronbach &#x03b1; reliability value. In the methods, the authors stated that a Cronbach value greater than 0.60 is acceptable, and a value greater than 0.80 is considered good. In the discussion, it is stated that a value greater than 0.70 indicates reliability and a value greater than 0.90 indicates unreliability. Generally, an alpha coefficient of 0.70 has often been regarded as an acceptable threshold for reliability.</p>
                    </list-item>
                </list>
            </p>
            <p>Is the work clearly and accurately presented and does it cite the current literature?</p>
            <p>Partly</p>
            <p>If applicable, is the statistical analysis and its interpretation appropriate?</p>
            <p>Partly</p>
            <p>Are all the source data underlying the results available to ensure full reproducibility?</p>
            <p>Yes</p>
            <p>Is the study design appropriate and is the work technically sound?</p>
            <p>Partly</p>
            <p>Are the conclusions drawn adequately supported by the results?</p>
            <p>Partly</p>
            <p>Are sufficient details of methods and analysis provided to allow replication by others?</p>
            <p>Partly</p>
            <p>Reviewer Expertise:</p>
            <p>Physiotherapy, Leprosy Rehabilitation, Sociology of Health</p>
            <p>I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard, however I have significant reservations, as outlined above.</p>
        </body>
    </sub-article>
    <sub-article article-type="reviewer-report" id="report203877">
        <front-stub>
            <article-id pub-id-type="doi">10.5256/f1000research.121556.r203877</article-id>
            <title-group>
                <article-title>Reviewer response for version 1</article-title>
            </title-group>
            <contrib-group>
                <contrib contrib-type="author">
                    <name>
                        <surname>Brasil Xavier</surname>
                        <given-names>Mar&#x00ed;lia</given-names>
                    </name>
                    <xref ref-type="aff" rid="r203877a1">1</xref>
                    <role>Referee</role>
                    <uri content-type="orcid">https://orcid.org/0000-0002-4727-3001</uri>
                </contrib>
                <contrib contrib-type="author">
                    <name>
                        <surname>Xavier Carneiro</surname>
                        <given-names>Thomaz</given-names>
                    </name>
                    <xref ref-type="aff" rid="r203877a2">2</xref>
                    <role>Co-referee</role>
                    <uri content-type="orcid">https://orcid.org/0000-0003-3869-0740</uri>
                </contrib>
                <aff id="r203877a1">
                    <label>1</label>Nucleo de Medicina Tropical, Laboratorio de Dermatologia Tropical, Universidade Federal do Para, Bel&#x00e9;m, State of Par&#x00e1;, Brazil</aff>
                <aff id="r203877a2">
                    <label>2</label>Nucleo de Medicina Tropical, Laboratorio de Epidemiologia, Territorialidade e Sociedade, Universidade Federal do Para, Bel&#x00e9;m, State of Par&#x00e1;, Brazil</aff>
            </contrib-group>
            <author-notes>
                <fn fn-type="conflict">
                    <p>
                        <bold>Competing interests: </bold>No competing interests were disclosed.</p>
                </fn>
            </author-notes>
            <pub-date pub-type="epub">
                <day>22</day>
                <month>9</month>
                <year>2023</year>
            </pub-date>
            <permissions>
                <copyright-statement>Copyright: &#x00a9; 2023 Brasil Xavier M and Xavier Carneiro T</copyright-statement>
                <copyright-year>2023</copyright-year>
                <license xlink:href="https://creativecommons.org/licenses/by/4.0/">
                    <license-p>This is an open access peer review report distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
                </license>
            </permissions>
            <related-article ext-link-type="doi" id="relatedArticleReport203877" related-article-type="peer-reviewed-article" xlink:href="10.12688/f1000research.109992.1"/>
            <custom-meta-group>
                <custom-meta>
                    <meta-name>recommendation</meta-name>
                    <meta-value>approve-with-reservations</meta-value>
                </custom-meta>
            </custom-meta-group>
        </front-stub>
        <body>
            <p>The manuscript proposes a specific questionnaire for evaluating the quality of life in leprosy patients and aims to assess the validity and reliability of the proposed tests in Indonesian patients. The addressed topic is relevant to clinical health assistance for leprosy patients. However, several areas need to be addressed before indexing: 
                <list list-type="order">
                    <list-item>
                        <p>The authors do not clearly indicate that this is the proposal of a novel questionnaire. Initially, it appears that they are testing a previously published method. If this is indeed a new questionnaire proposed by the authors, a thorough description of its development and composition is necessary, including the participation of experts in its creation, if it is the case.</p>
                    </list-item>
                    <list-item>
                        <p>The authors should provide more background information on other instruments used to assess the quality of life in leprosy patients, such as adapted WHO questionnaires. This context will help readers understand the significance of the proposed questionnaire.</p>
                    </list-item>
                    <list-item>
                        <p>Citations for the statistical methodology used to evaluate the validity and reliability of the Leprosy Quality of Life Questionnaire (KUKUH) are mentioned in the discussion but not in the methodology section. It's important to include these citations in the methodology section for clarity and transparency.</p>
                    </list-item>
                    <list-item>
                        <p>There is inconsistency in the description of the Cronbach &#x03b1; reliability value. In one part, it is mentioned that a value greater than 0.60 is acceptable, and a value greater than or equal to 0.80 is considered good. However, in the discussion, it is stated that a value greater than 0.70 indicates reliability and a value greater than 0.90 indicates unreliability. This discrepancy needs clarification, as it affects the interpretation of the reliability of the Social and Environment questions, which were reported as (summarized) 1.000 in the results section.&#x00a0;The same goes for the sentence "The reliability test results were deemed satisfactory, with Cronbach's alpha &gt; 0.6", incoherent with the &gt;0.70 cut-off mentioned.</p>
                    </list-item>
                    <list-item>
                        <p>The manuscript should clearly state that the study's population is small and composition, especially considering the diversity of disease and disability within the leprosy spectrum. This is important information for readers to understand the limitations of the study and the generalizability of the findings.</p>
                    </list-item>
                    <list-item>
                        <p>The discussion should be improved by incorporating relevant literature, even if it includes adapted questionnaires previously mentioned. This will help place the research in a broader context and provide more robust support for the study's findings and conclusions.</p>
                    </list-item>
                    <list-item>
                        <p>Please address these issues to enhance the quality and clarity of your manuscript before revising.</p>
                    </list-item>
                </list>
            </p>
            <p>Is the work clearly and accurately presented and does it cite the current literature?</p>
            <p>Partly</p>
            <p>If applicable, is the statistical analysis and its interpretation appropriate?</p>
            <p>Partly</p>
            <p>Are all the source data underlying the results available to ensure full reproducibility?</p>
            <p>Yes</p>
            <p>Is the study design appropriate and is the work technically sound?</p>
            <p>Partly</p>
            <p>Are the conclusions drawn adequately supported by the results?</p>
            <p>Yes</p>
            <p>Are sufficient details of methods and analysis provided to allow replication by others?</p>
            <p>Partly</p>
            <p>Reviewer Expertise:</p>
            <p>Dermatology, tropical dermatology, leprosy, infectious diseases.</p>
            <p>We confirm that we have read this submission and believe that we have an appropriate level of expertise to confirm that it is of an acceptable scientific standard, however we have significant reservations, as outlined above.</p>
        </body>
    </sub-article>
</article>
